Diagonal Bio AB's market cap is currently €1.19M. The company's EPS TTM is €-0.00018162400000000002; its P/E ratio is ―; Diagonal Bio AB is scheduled to report earnings on August 22, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
